Japan Surgical Sutures Market

Japan Surgical Sutures Market Insights Forecasts to 2035

• The Japan Surgical Sutures Market Size Was Estimated at USD 305.70 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 6.3% from 2025 to 2035
• The Japan Surgical Sutures Market Size is Expected to Reach USD 598.89 Million by 2035

According to a research report published by Decision Advisors & Consulting, the Japan Surgical Sutures Market size is anticipated to reach USD 598.89 Million by 2035, growing at a CAGR of 6.3% from 2025 to 2035. The Japan surgical sutures market is driven by the increase in surgical procedures being performed for both replacement and repair as well as advances being made in the area of technology regarding suture materials and/or products that meet a need for specialized, quality items, that are used especially for minimally invasive surgical procedures.

Market Overview

The surgical sutures market in Japan includes the sale of surgical threads and other associated products that are utilized to close wounds and tissue in Japan's healthcare industry. Factors such as an ageing population, increased surgical volumes, and improvements in medical technology have contributed to this growth, as has the expansion of the types, materials and uses of sutures available, including knot-free and dissolvable sutures.

The Japan surgical sutures market is mainly driven by the increase in surgeries being performed because of an increase in the number of people who are becoming older and have chronic diseases. As reported in Japan Statistics Bureau on May 1, 2013, approximately 35.9 million, or 28.7%, of the population was made up of seniors over 65 years of age. This figure also represents the largest percentage of seniors as a whole throughout the World.There are about 35.9 million seniors living in Japan, with female seniors numbering about 19.3 million and male seniors at about 16.7 million. This means that approximately 89% of Japan's overall population consists of individuals aged 65 or older. The estimate for the percentage of the Japanese population that will be comprised of seniors (65+) by 2019 is about 37%.

Japan also has one of the longest average life expectancies (83.8 years), so there will be an increasing number of new seniorcitizen patients who will experience an increasing number of surgical cases to manage the consequences of chronic diseases. Chronic conditions such as cardiovascular disease, orthopedic disease, and cancer are prevalent among seniors. The recent advances in the use of less invasive surgical techniques are creating greater demand for the use of quality sutures that promote more effective wound healing and faster recovery, as pointed out in the Japan surgical sutures market report. In addition, through creating access to advanced medical products, government programs to promote the development of healthcare infrastructure and technology innovation are helping to drive the growth of the market.

Report Coverage                      

This research report categorizes the market for the Japan surgical sutures market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan surgical sutures market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan surgical sutures market.

Driving Factors                                          

The surgical sutures markets in Japan are driven by increased use of biodegradable and antimicrobial sutures. This growing interest in biodegradable sutures specifically, those that are manufactured from polyglycolic and polylactic acids is attributed to the natural breakdown of these materials and their respective ease of use (i.e., no need for suture removal at the end of healing), as well as decreased potential for developing an infection.

Restraining Factors                                      

The surgical sutures market in Japan is restrained by this increase is due in part to the high price of these products, stringent government regulations, and the growing acceptance of minimally invasive and sutureless techniques to repair damaged tissue.

Market Segmentation

The Japan surgical sutures market share is categorized by type, application and filament.                                  

• The absorbable segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Japan surgical sutures market is segmented by type into absorbable, nonabsorbable. Among these, the absorbable segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is driven by Due to an increase in surgical volume, the benefits of quicker healing, a decrease in chance of infection with biodegradable sutures, and an increase in market demand for biodegradable sutures.

• The cardiovascular surgery segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

The Japan surgical sutures market is segmented by application into ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, and others. Among these, the cardiovascular surgery segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growth of the segment is due to increase in the number of cardiac procedures performed, the rising age of the population, and the increased use of advanced types of sutures improving the outcomes of surgical procedures.

• The multivalent segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

The Japan surgical sutures market is segmented by filament into monovalent, multivalent. Among these, the multivalent segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growth of the segment is due to Tensile strength, adequate knot hold, and wide use for complicated surgical procedures across multiple specialties.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan surgical sutures market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Ethicon Inc.
• Medtronic Plc
• Arthrex Inc.
• Smith & Nephew Plc
• B. Braun Melsungen AG
• DemeTECH Corporation
• Kono Seisakusho Co., Ltd.                            

Key Target Audience                         

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In January 07, 2025: Kaken Pharmaceutical of Japan entered into a licensing agreement valued at USD 1.2 Billion with Johnson & Johnson for the worldwide development, production, and marketing of its STAT6 inhibitor program, which encompasses KP-723. Kaken is responsible for concluding Phase I trials before Johnson & Johnson assumes control of global clinical development, while Kaken will maintain commercialization rights within Japan. The agreement features an initial payment of USD 30 Million, milestone-related payments that could reach up to USD 1.2175 Billion, along with royalties on international sales.                          

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the Japan Surgical Sutures Market based on the below-mentioned segments:

Japan Surgical Sutures Market, By Type

• Absorbable
• Non absorbable

Japan Surgical Sutures Market, By Application

• Ophthalmic Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• Neurological Surgery
• Others

Japan Surgical Sutures Market, Filament

• Monovalent
• Multivalent

FAQ’s   

Q: What was the size of the Japan surgical sutures market in 2024?

A: The market size was USD 305.70 million in 2024.

Q: What is the expected market size by 2035?

A: It is projected to reach USD 598.89 million by 2035.

Q: What is the CAGR of the Japan surgical sutures market for 2025–2035?

A: The market is forecasted to grow at a CAGR of 6.3%.

Q: Which type segment held the largest market share in 2024?

A: The absorbable sutures segment held the largest share in 2024.

Q: Which application segment dominated the market in 2024?

A: The cardiovascular surgery segment dominated the market.

Q: What factors are driving the growth of Japan’s surgical sutures market?

A: Growth is driven by rising surgical volumes, aging population, chronic diseases, and advancements in suture materials and technology